Baxion
Screening
Tags
Alerts
Theme
Vanda Pharmaceuticals Inc.
VNDA
·
NASDAQ
·
$6.22
Share Price as of 11/2
·
$374M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q3 ended 09/30/26
10/29/26
10-Q
Q2 ended 06/30/26
08/06/26
10-Q
Q1 ended 03/31/26
05/07/26
10-K
FY 2025
02/12/26
10-Q
Q3 ended 09/30/25
10/30/25
Disclosures
Filter
8-K
Current report
10/28/26
8-K
Current report
08/05/26
8-K
Current report
06/05/26
8-K
Current report
05/06/26
8-K
Current report
04/22/26
Prospectuses and Registrations
Filter
S-8
Registration of securities for employees
06/05/26
S-3
Shelf registration
02/12/26
S-8
Registration of securities for employees
06/05/25
S-8
Registration of securities for employees
05/21/24
S-8
Registration of securities for employees
06/08/23
Proxies
Filter
DEF 14A
Definitive proxy
04/23/26
DEFA14A
Additional proxy materials
04/23/26
DEFA14A
Additional proxy materials
05/27/25
DEF 14A
Definitive proxy
04/25/25
DEFA14A
Additional proxy materials
04/25/25
Ownership
Filter
SC 13G
Beneficial ownership
10/27/26
SC 13G/A
Beneficial ownership (amended)
10/09/26
SC 13G
Beneficial ownership
08/19/26
SC 13G
Beneficial ownership
08/13/26
Form 3
Initial insider ownership
06/08/26
Other
Filter
EFFECT
Request for effectiveness
05/05/26
CORRESP
Correspondence with the SEC
04/24/26
ARS
Annual report to shareholders
04/23/26
UPLOAD
Letter from the SEC
02/18/26
ARS
Annual report to shareholders
04/25/25
Latest Filings
Filter
10-Q
Q3 ended 09/30/26
10/29/26
8-K
Current report
10/28/26
10-Q
Q2 ended 06/30/26
08/06/26
8-K
Current report
08/05/26
8-K
Current report
06/05/26
Ownership
Filter
SC 13G
Beneficial ownership
10/27/26
SC 13G/A
Beneficial ownership (amended)
10/09/26
SC 13G
Beneficial ownership
08/19/26
SC 13G
Beneficial ownership
08/13/26
Form 3
Initial insider ownership
06/08/26